| 注册
首页|期刊导航|癌症(英文版)|Cancer chemoprevention through dietary flavonoids:what's limiting?

Cancer chemoprevention through dietary flavonoids:what's limiting?

Haneen Amawi Charles R. Ashby Jr Amit K. Tiwari

癌症(英文版)2017,Vol.36Issue(10):455-467,13.
癌症(英文版)2017,Vol.36Issue(10):455-467,13.DOI:10.1186/s40880-017-0217-4

Cancer chemoprevention through dietary flavonoids:what's limiting?

Cancer chemoprevention through dietary flavonoids:what's limiting?

Haneen Amawi 1Charles R. Ashby Jr 2Amit K. Tiwari1

作者信息

  • 1. Department of Pharmacology and Systems Therapeutics, College of Phar-macy and Pharmaceutical Sciences, University of Toledo, Toledo, OH 43560, USA
  • 2. Pharmaceutical Sciences, College of Pharmacy, St. John's University, Queens, NY 11432, USA
  • 折叠

摘要

关键词

Flavonoids/Chemoprevention/Silybin/Silymarin/Natural product drug development/Pharmacokinetic challenges

Key words

Flavonoids/Chemoprevention/Silybin/Silymarin/Natural product drug development/Pharmacokinetic challenges

引用本文复制引用

Haneen Amawi,Charles R. Ashby Jr,Amit K. Tiwari..Cancer chemoprevention through dietary flavonoids:what's limiting?[J].癌症(英文版),2017,36(10):455-467,13.

基金项目

We thank Ms. Charisse Montgomery, University of Toledo for critical reading of this manuscript. This work was supported by seed-fund to AKT from Depart-ment of Pharmacology and Experimental Therapeutics at UT. ()

癌症(英文版)

OACSCDCSTPCDSCI

1000-467X

访问量0
|
下载量0
段落导航相关论文